Biofrontera Inc.
BFRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Other share classesBFRIW
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Biofrontera Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Biofrontera Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Luebbert Hermann | CEO & Chairman | 352,711 | Jul 29, 2026 | 2 |
| Leffler Eugene Frederick | Chief Financial Officer | 206,250 | Jul 29, 2026 | 2 |
| Borer John J III | Director | – | Mar 6, 2026 | 1 |
| Hoffman Beth J. | Director | – | Mar 6, 2026 | 1 |
| Weber Kevin Daniel | Director | – | Mar 6, 2026 | 1 |
| Lanckriet Heikki | Director | – | Mar 6, 2026 | 1 |
| Jones George Patrick | Chief Commercial Officer | – | Mar 6, 2026 | 1 |
| Biofrontera AG | Director, 10% Owner | – | Sep 18, 2025 | 0 |
| Monaco Erica L. | Chief Executive Officer | 133,025 | May 22, 2023 | 0 |
| Gates Erica F. | Senior Director Finance | – | Jan 12, 2023 | 0 |
| Wedge Loretta M. | Director | – | Jun 6, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2025 (view filing) | Sep 16 | 2 days | Biofrontera AGDirector, 10% Owner | PPurchase | +4.83M | – | – | –3.02K after | Derivative |